Company intelligence / Profile preview

Gensco Laboratories

Miami, Florida, United States

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Gensco Laboratories is a specialty pharmaceutical company focused on the development and commercialization of prescription products for pain management and other therapeutic areas. The company specializes in topical delivery systems designed to improve patient compliance and safety compared to systemic treatments. Their portfolio includes branded products such as LiDORX, Terocin, and SpeedGel, which target conditions like neuropathic pain and musculoskeletal inflammation. Gensco emphasizes research-driven solutions to address unmet needs in the healthcare market through innovative drug delivery technologies.

Therapeutic areas: RheumatologyNeurology
Modalities: Small moleculeTopical
Industry: Biotech

Drug pipeline

1 asset

SpeedGel Rx

Unknown

Beyond the preview

Go deeper on Gensco Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gensco Laboratories.

Explore the full profile